Alerta De Seguridad para Albograft Vascular Graft

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por LeMaitre Vascular.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2013-07-25
  • Fecha de publicación del evento
    2013-07-25
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: lemaitre albograft vascular graft the united states food and drug administration (fda) has issued a medical device safety alert concerning albograft vascular graft [model no.: amc1408, amc1506, amc1608, amc1809, amc1810, amc2010, amc4007, amc4008, amc6006, amc6007, amc6008, atc1526, atc1530, atc3016, atc3018, atc3024, atc3026; batch no.: 56890a], manufactured by lemaitre vascular, inc . the affected devices were manufactured in april 2011, and distributed from april 2011 through june 2013. according to the fda, the albograft vascular graft is designed to replace or repair a damaged artery with an abnormal enlargement (aneurysm) or a blockage (occlusion) caused by a disease. this product was recalled due to blood leaking from the surface of the graft after implantation. this product may cause serious adverse health consequences, including death. for details, please visit the following fda websites: http://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm362217.Htm http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm362204.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 25 july 2013.

Device

Manufacturer